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Abstract
This qualitative study of travel-related risk behaviours of Slovene injection drug users was based on interviews with
individuals enrolled in drug addiction treatment programmes run by three regional centres for prevention and
treatment of drug addiction. The primary objective of the study was to analyse behaviour patterns and practices of
injection drug users during travel.
Methods: Travel-related problems of Slovene injection drug users were identified on the basis of data obtained by
25 in-depth interviews. A semi-structured questionnaire with 13 open-ended questions was developed after a
preliminary study and review of the literature, and on the basis of experience with the treatment of drug addiction
in Slovenia.
Results: The sample comprised 25 individuals, 18 men and seven women, aged 25 to 53 years. The interviews
were 10 to 30 minutes long. The results obtained were presented as identified risk behaviours. Five categories
were generated, providing information on the following topics: procurement of illicit drugs, criminal acts/
environment, HIV and hepatitis B and C infections, storage and transport of substitution medication and pre-travel
health protection. The first three categories comprise the injection drug users’ risk behaviours that are most
frequently explored in the literature. The other two categories - storage and transport of medication across the
border and pre-travel health protection - reflect national specificities and the effectiveness of substitution treatment
programmes. The majority of participants denied having shared needles and other injecting equipment when
travelling. Participants who had no doctor’s certificate had recourse to various forms of risk behaviour, finding a
number of ways to hide the medication at the border.
Conclusion: This qualitative study provides insight into potential travel-related risk behaviour of injection drug users
from two Slovene regions - central and coastal. The potential value of this qualitative study is primarily in the
identification of potential risk behaviour of Slovene injection drug users travelling abroad. The study shows that
injection drug users’ experiences can contribute to better and more efficient treatment of drug addiction in Slovenia.
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Background
Estimates of the prevalence of illicit drug use and
related health risks in Slovenia and the formulation of
harm reduction strategies should be based on accurate
analysis of the current situtation at various levels [1,2].
An estimated 7,500 individuals use drugs in a proble-
matic manner [3]. Risks associated with sharing needles
and syringes, mixing drugs (speedball), vascular injuries
and unprotected sex are most frequently reported by
drug users in Slovenia [2,4].
According to the 2008 data provided by 18 Slovene
centres for prevention and treatment of drug addiction
(CPTDAs), 3,332 of a total of 4,429 individuals were
enrolled in opoid substitution treatment programmes
(OSTP) [2]. The first CPTDA was founded in Koper to
address the issue of dramatically increasing illicit drug
use at the Slovene coast at the beginning of 1990 [5-7].
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During our study, treatment of drug addiction was pro-
vided for 583 patients in Ljubljana, 236 in Koper and
191 in Piran, i.e., for 1,010 patients or nearly one-third
of the total number of individuals enrolled in OSTP [8].
In Slovenia, as in other countries, methadone is the
most commonly used medication for treatment of opoid
addiction. The treatment is directed towards decreasing
illicit drug use and reducing risks associated with pro-
blematic drug use, especially the risk of overdose and
infection with HIV and hepatitis B and C viruses [3,5,9].
Physicians have full authority to dispense substitution
medication to their patients. They may prescribe and
dispense several takeaway doses of methadone to
patients planning to travel outside their home environ-
ment [10]. According to the treatment protocol cur-
rently used in Slovenia, intending travellers are allowed
to take with them a 14-day supply of medication. In
addition, they are given a treatment certificate, required
for transfer of substitution medication across the border
[5,6].
Injecting drug users (IDUs) who have decided to enter
an OSTP have to meet the programme requirements.
Given that ordinary life situations may pose risks to these
individuals, travel is another dimension of this issue in
that it can lead to increased risk of exposure to risky
behaviours [11,12]. IDUs face many problems when tra-
velling; these may be due either to their behaviour and
habits or to legal institutional, procedural and broader
social factors, characteristic of destination countries [13].
IDUs most commonly decide to travel in order to
escape legal problems or social pressures in their home
environment, to enter a drug treatment programme
abroad, or to conduct illegal activities related to the pro-
curement and selling of drugs [12]. Exposure to HIV and
to hepatitis B and C virus infections is the most frequent
risk described in earlier research. Individuals that are
most at risk are heroin users, who share injecting equip-
ment, engage in unprotected sex or have multiple sex
partners [1,12,14]. Another risk factor is the unknown
environment in destination countries. Most of these indi-
viduals find themselves in high-risk situations because
they lack money to purchase drugs and, when faced with
an abstinence crisis, they are very likely to engage in
criminal activities [15-17].
Risk-taking behavioural patterns of IDUs depend on
both the individual and on the surrounding social
environment [18,19]. Their decision to engage in risk-
taking behaviour is thus not made only on the basis of
critical reflection, it is more often determined by social
factors [20]. Individual patterns of illicit drug users’
risk-taking behaviour have been explored in several
studies [12,20-22]. Many of these studies are ethno-
graphic in nature and use a qualitative approach to
data collection and processing, with the aim of improv-
ing understanding of illicit drug use and of providing
answers to this problem [23-26].
An individual’s activities constitute the first group of
travel-related risks. IDUs are most likely to be exposed
to the risk of HIV and/or hepatitis B and C infection
[4,14,27,28] when travelling, primarily because of sharing
injecting equipment and engaging in unprotected sex.
The HIV infection rate in Slovenia is low, i.e., less than
one person per 1,000 of the population. The rate has
shown a steady upward trend, however: 232 cases of HIV
infection and 28 AIDS-related deaths were documented
during the period 2000-2009 [29]. A study conducted in
2008 among voluntarily tested IDUs who had access to
needle exchange programmes identified HIV infection in
less than 1% of participants; 4.2% had hepatitis B infection
and 22.3% were infected with the hepatitis C virus [30].
Lee and co-authors explored the travel experiences of a
sample of 160 drug users and 44 non-drug users recruited
as part of a study of HIV infection risks. Of the sample,
47% (96/204) reported travel experiences in the previous
ten years. Drug injecting, safety of sex, number of sexual
partners and duration of travel were investigated in asso-
ciation with drug use and HIV serostatus. Two significant
relationships emerged: travelling drug users were more
likely to inject drugs and to set off on longer trips than
non-drug users. No statistically singificant differences in
sex risk behaviour during travel were found between drug
users and non-drug users or between drug-injectors and
non-injectors. A comparison between risk behaviours
undertaken at home and when travelling revealed signifi-
cant differences in drug injection risks [12].
The environment is another risk factor for IDUs.
Increased risk is associated with a number of factors,
including poverty, joblessness, poor housing conditions,
educational disadvantage, overpopulation and criminality
[18].
Risks in the third category are related to the country
from which a traveller comes. IDUs in Slovenia who are
frequent travellers are offered information in CPTDAs
on how to prepare for travel [3].
Since the prohibitory model for drug treatment, which
stresses total abstinence as the final treatment target, has
been losing credibility, alternative forms of counselling will
have to be considered in the context of harm-reduction
policy [1,5,10]. The aims include: providing better infor-
mation about potential risks of disease and specific
features of destination countries, about the required medi-
cal certificate and the risks associated with the transport
of substitution medications across borders [7,14].
The objective of this study was to explore the beha-
viour patterns and travel experiences of IDUs during
travel and improved harm-reduction strategies for drug
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users when travelling. The findings being aimed at
stimulating further research into the control of travel-
related risks.
Methods
We present a qualitative study of 25 in-depth interviews
conducted with IDUs involved in OSTP in Ljubljana,
Koper and Piran CPTDAs [31]. The personnel of these
CPTDAs were asked to help us make contact with this
hard-to-reach population group. Interviews were con-
ducted on a voluntary basis. The study inclusion criter-
ion was travel abroad during drug being treated in
OSTP in year 2009.
Data were collected using in-depth semi-structured
interviews, including 13 open-ended questions. A semi-
structured questionnaire was developed after a prelimin-
ary study and review of the literature and on the basis
of experience with the treatment of opoid addiction in
Slovenia [5-7].
Study participants were given written information
about the study and were asked to allow digital record-
ing and note taking. Discussions, participants’ names,
comments and answers remained confidential. All parti-
cipants were able to answer all questions.
The topics covered in interviews included reasons for
drug use and seeking medical counselling, description of
drug injection equipment and behaviours, problems aris-
ing during travel and during transfer of substitution
medication across borders, travel-related risk behaviour
and type of assistance available abroad.
The interviews were conducted in Slovene. Verbatim
transcriptions of quotes extracted from interviews were
done by native Slovene speakers. Data were digitally
recorded and transcribed [31,32].
Data collection/analysis
Qualitative data collected between May and July 2009
were used.
Interview transcripts were read and processed by two
independent investigators. Researchers used manual
coding of basic textual material.
We analysed interview transcripts and searched for
pre-determined words and phrases that best matched
the answers to 13 questions. The search for pre-deter-
mined answers to each question was conducted over the
entire text of the interview, the frequency depending on
the number of topics searched for. We identified 57
codes likely to describe common characteristics of drug
users [27,33].
The selection of quotations and their codes was done
together with a comparison of respondents. Individual
categories of responses were thus clarified in terms of
importance, similarities and differences.
Codes were generated regarding travel-related
problems reported by the Slovene IDUs interviewed.
Categories are the extraction of behaviour pattern codes.
The qualitative database (interview transcripts) was
broken down, and data were shown separately for each
participant. Next, larger topics that connected similar
answers were formed.
The coding scheme thus consisted of three steps,
using the principle of progression from general (large)
to ever-narrower subtopics. The coded contents were
then entered into a theoretically devised risk factor
frame.
Ethical considerations
The study was conducted according to the guidelines of
the Medical Ethics Committee of the Republic of Slove-
nia and was approved by this body in August 2008.
Study participants gave informed consent to audiotaping
and a literal transcription of interviews.
Results
Interviews lasted 10 to 30 minutes, 387 minutes in total.
The sample included 25 participants, 18 males and 7
females, ranging in age from 28 to 53 years. Some partici-
pants made trips to distant locations, mostly in Asia and
America, but only stayed there for a month or less,
whereas others travelled to Europe and/or other conti-
nents and stayed there, for various reasons, for several
months. Some participants set off on a trip with no fixed
plans concerning the destination and length of travel; in
these cases, drugs were the principal motivation behind
travel:
Categories of risk-taking behavious are: procurement
of illicit drugs, criminal acts/environment, HIV and
hepatitis B and C virus infections, storage and transport
of substitution medication and pre-travel health
protection.
Procurement of illicit drugs
Procurement of illicit drugs constitutes the first category
of risk-taking behaviour, reported by six study partici-
pants. For three of them, procuring drugs was the only
motivation behind travel.
Generally, they had no difficulty procuring drugs,
although this activity invariably put them into various
high-risk situations, which reportedly happened in both
European and distant Asian destination countries alike.
“Drugs were the motivation behind all my travelling -
Pakistan, Bangladesh, India, Thailand, most often. (...)
There was no problem whatsoever to get it there; at that
time, every carriage driver and, where there were tourists,
every taxi driver had a pack and he waved to you if you
were interested. For example, in Pakistan, India,
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especially Goa, you had no problem whatsoever... fifteen
approached you before you managed to go up to any of
them.(...)” (male, age 48).
“Now, you seek and you find. Even when I went for the
first time, it didn’t take long. I think it was more diffi-
cult, ‘cause it’s not like in Europe, like it used to be in
Holland, they don’t sell in the street...they didn’t at that
time...but...who seeks, I think, always finds (...) I was
attacked in Basel, in Rome, in Vienna"(male, age 50).
Criminal acts/environment
Criminal acts belong to the second category of risk
behaviour. None of the study participants reported com-
mitting a criminal offence to get money for drugs.
Those who did engage in criminal activity said they
acted spontaneously. Illegal activities were sometimes
the goal of their travels and also a means of earning
some extra money. Two respondents stressed problems
with the police and the criminal environment in which
they found themselves when procuring and/or selling
drugs.
“For instance, they know me so well in Dimitrograd
that the Serbian custom officers asked me jokingly where
I had my 200 grams for my own use. They told me they
knew I didn’t come all the way from Ljubljana just to
buy three pairs of jeans every three months. (...). So
that... And then, when I was selling...., I had to avoid
this, too....They knew me in Rome after a couple of
months, and they often searched me” (male, age 50).
“Yeah, smuggling is most risky. And it used to end
badly, too. ...well, in Germany, an Italian guy gave me
away...it was about being betrayed most of the time. And
in Germany, I once shut myself in a cellar, the cops
found it but seeing my injection punctures, they thought.
(...). I used to cross the border of Myanmar; I went illeg-
ally across two hills or so - once I nearly got killed - to
buy for half the price, when I was short of money” (male,
age 48).
Some other activities not directly related to drugs
were also identified as criminal. Two study participants
engaged in the illegal transport of people across a bor-
der and one used forged bank cards to draw money.
Drugs invariably emerged as an additional factor
increasing the risk and the likelihood of unexpected
events. The respondents were of the same opinion:
“I’ve been to Croatia, Dalmata. I spent six months in
prison in Italy. I went to Germany (...) I was taking peo-
ple across. (...). Sometimes I had my own stuff, but I like
didn’t dare to carry it across the border. Though we
went there through a hole, that Schengen border, and
back across the border, I nevertheless, they searched me
once, but they found nothing, luckily I’d stuck it inside
my socks, it’s only there they didn’t look. They usually
do, so I said then that I was lucky, but now, never more”
(male, age 32).
HIV and hepatitis B and C virus infections
The possibility of infection with HIV and hepatitis B
and C viruses constitutes the third risk category. Some
participants admitted to sharing drug injecting equip-
ment with other drug users without thought because
they had no sterile syringes and needles, thereby
increasing their risk of getting infected. However, the
majority denied sharing injecting equipment while tra-
velling and reported that they did not run the risk of
HIV and/or hepatitis B and C infection. Only two parti-
cipants shared their injecting equipment while travelling,
explaining that an abstinence crisis and non-availability
of sterile needles and syringes were the main reasons for
their taking risks.
“... a used syringe - definitely don’t know, if there is one
who would, I mean, wash this syringe, hot water, don’t
know what, if there is bleach. (...). Yeah, I used it” (male,
age 48).
“Somebody else’s? Yes, I did if I had none. We, once, we
were five of us, we had one (needle), we were on one....
Because there was no place and, you don’t care, you
can’t, can you. Otherwise I exchanged, right, also had
my own, but if there was no other option, me too” (male,
age 50).
Two respondents, who travelled abroad alone and for
an extended period of time, did not use condoms, sim-
ply because they did not have any when necessary.
One participant infected with hepatitis C was aware of
his risk behaviour, but admitted to having often engaged
in unprotected sex in the past. He also said that most
injecting drug users in his home environment practiced
unprotected sex.
“Of course, unprotected sex, this has happened all the
time, hasn’t it, but now we’re more aware, so I don’t do
it any longer. Even here in Metelkova, nobody will use
protection but we’re a little more aware now, nearly all
of us have hepatitis C, some of us use it nevertheless”
(male, age 36).
Storage and transport of substitution medication
The fourth category comprised topics that respondents
identified as key problems encountered in storing and
transporting substitution medication across borders.
Eighteen of the 25 study participants reported having
applied for and obtaining a medical certificate required
for the transport of substitution medication prior to
every border crossing. The reasons for not having the
document were that customs never check the certificate
and that occasionally they did not apply for a certificate
because of negligence.
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Participants who had no certificate had recourse to
various forms of risk behaviour, finding a number of
ways to hide the medication at the border.
The issue of drug storage emerged on several occa-
sions. The majority of study participants were treated
with liquid methadone, which is difficult to hide. They
often put the drug mixed with fruit juice in a plastic
bottle, but a problem arose when they started drinking
and did not know how much liquid was left in the bot-
tle, exactly what daily dose they had to take.
“I never needed it (a certificate), it was not required
really, but as realize now, it is required” (male, age 40).
“And I received it (methadone) from a female doctor,
she just trusted me, but therefore I had to smuggle it. So
I put it into orange juice, right, threw one bottle and a
sandwich into it and set off” (male, age 48).
“So I preferred to hide it, I poured it in a bottle, a
Fanta can once, and in a fruit juice bottle once, ‘cause
fruit juice is mixed with methadone and I mixed them
together. I was afraid of problems, because Croatia, Italy,
I don’t know if they tolerate these things. I preferred to
hide it” (male, age 31).
The respondents consider crossing the national border
and undergoing customs control as high-risk situations.
Some of them reported minor problems crossing the
borders of some neighbouring countries. These are
often also experienced by individuals with a valid cerifi-
cate for legal transport of substitution medication across
the border.
“Yes, as a matter of fact. I get, we get this certificate
allowing us to carry a certain number of bottles across
but, as they say, not all customs officers stick to it,
I don’t know in which countries, they refuse you entry,
and it’s said they had to pour it away, in Croatia, too”
(male, age 28).
Pre-travel health protection
The fifth category includes problems encountered by par-
ticipants when preparing for travel. CPTDAs provide per-
sonal health protection, particularly vaccination against
hepatitis, and offer information on healthcare services
available abroad. Intending travellers may be referred to
travel clinics operated within the network of healthcare
centres. Travellers get information there on the destina-
tion country and potential health hazards, as well as on
the health protection measures required for entry.
The main sources of information reported by partici-
pants included CPTDAs, some non-governmental orga-
nisations and advice from friends. The Internet was
listed as a very important source of information about
areas to which they were travelling. The major problem
reported was lack of information and inadequate
instructions on what travellers should do when they
have run out of substitution medications.
“I think I even called last year when we went to Thai-
land, that I called to ask about the pills in Thailand,
but we got two different pieces of information. Some said
it was necessary, and others said it was pointless, so we
simply didn’t...” (male, age 36).
“Yes, but even here, in Ljubljana, no doctor will sign if
you’ve run out of methadone, or if it has been stolen
from you, you go to the emergency unit, but they already
kick your ass at the door. You can’t get methadone abso-
lutely anywhere on Saturdays, if, let’s say, somebody has
stolen it from you. Nobody gives a damn, that’s your pro-
blem. I wonder how these things would be abroad”
(female, age 44).
Discussion
This qualitative study provides insight into risk beha-
viours in which IDUs from two Slovene regions engaged
when travelling abroad.
We identified five categories of travel-related risk
behaviour. Drug procurement, criminal acts/environ-
ment and the risk of acquiring HIV and/or hepatitis B
and C virus infection have been frequently explored in
the literature as risk-taking behaviour patterns of IDUs
[15,17,20,21]. Storage and transport of drugs across bor-
ders and pre-travel health protection include behaviour
patterns that are related to national specificities and the
implementation of national drug policy [1,3].
Despite numerous risks resulting from the interplay of
individual and social factors, some participants con-
sciously chose to set off on a trip, the only motivation
behind their travel being to procure less expensive drugs.
As a result, they were very likely to commit illegal activ-
ities and become involved in the criminal environment,
in which drugs constitute both cause and effect of risk-
taking behaviour [15,18]. Other criminal activities
reported by study participants were related to their
attempts to make fast and easy money, and involved
transporting people across the border, drug dealing and
credit card abuse. In all these situations, study partici-
pants were exposed to numerous threats of physical vio-
lence, clear evidence of risky nature of their behaviour.
The increased risk of infection with HIV and/or
hepatitis B or C viruses in the study participants was
attributable to their inconsiderate and irresponsible
behaviour. Only two of them (male, age 48 and male,
age 50), admitted to having taken risks during travel;
their high-risk behaviour was confirmed by quotes
from the interviews. The majority of participants
denied having shared needles and other injecting
equipment when travelling. Risk of infection is asso-
ciated with unprotected sex.
The results showed, however, that the travel-related
behaviour of the study participants was less risky and
much more responsible and thoughtful than expected.
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As reported by some investigators, 5% to 50% of
short-term travellers engage in risk behaviour by having
sex without using condoms; the percentage is higher for
long-term travellers. HIV-infected individuals constitute
an especially high-risk group [14,27,28]. Other authors
maintain that 23.3% of persons travelling abroad have
sex with new partners and (only) 58.1% of them use
condoms consistently [28].
OSTP have been generally recognized as an efficient
tool for reducing drug-related harm, criminal activity
and individual health risk rates [5]. One of the charac-
teristics of these programmes is that drug users who, for
various reasons, cannot attend CPTDAs on a daily basis
are granted takeaway doses of substitution medication
for home use [10]. Providing of takeaway substitution
medication in a form most suitable for travel has an
important impact on its transport across borders.
Prescribing substitution medications for long-term
trips in itself represents a risk if it contributes to substi-
tution drug trading on the black market [3,10]. Most
study participants reported travelling with a certificate
required for the legal transport of drugs across a border.
Two study participants (male, age 48 and male, age 50),
who were prone to engaging in risk-taking behaviour
and travelled long term, reported having problems with
the transport of medication across borders; the inconve-
niences they experienced seemed to be attributable to
individual risk factors [18].
The reliability of the results of this qualitative content
analysis therefore depends mostly on the accuracy of
collection procedures and on the way of conducting
interviews and categorizing risk behaviour [34]. The
issue of validity, which re-emerged in data interpretation
and categorization of risk behaviour, was addressed by
using the above described coding method and by includ-
ing two independent investigators [32,33].
Conclusion
The value of this qualitative research project is primarily
in the identification of potential risk behaviours of Slo-
vene IDUs travelling abroad, which included: sharing
injecting equipment related to the non-availability of
sterile needles and other injecting paraphernalia, unpro-
tected sex, transport of substitute medication across the
border, drug storage problems, drug procurement
abroad and criminal acts.
In conclusion, Slovene IDUs do not take great risks
while traveling, even when they talk about sex as a pos-
sible mode of transmission of various diseases. They
have a good understanding of their illness (addiction)
and try to adjust to all life situations to the greatest
extent possible. They are often the target of various
forms of discrimination and stigmatization but they
mostly cope with the problem situations successfully, as
evidenced by the fact that they have families and job,
and that they travel. The study showed that Slovene
IDUs behave reasonably while traveling and that they
tend to avoid situations defined as risky in this report.
IDUs experiences can contribute to better and more
efficient treatment of opioid addiction in Slovenia. Pro-
blems experienced by IDUs during international travel,
and the identified risk behaviour patterns help us better
to understand the specific needs of these individuals.
Interaction between service users and physicians and
other CPTDAs staff seems particularly important, there-
fore further improvements would be welcome in this
area. This opinion was also expressed by the study parti-
cipants. The important role of supportive therapy, edu-
cation of DUs, their relatives and partners, group
therapy and psychosocial support should be mentioned
in this context [35,36].
Study participants favour counselling offered by
CPTDAs as part of pre-travel preparation. Further
improvements were suggested in terms of (more) accu-
rate information and a more flexible approach to the
issue of takeaway substitution medication. In the partici-
pants’ opinion, these improvements would reduce the
risks that they had experienced while travelling.
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